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Introduction 
This master’s paper is a program and evaluation plan for preventing vision loss due to 
complications from diabetes.  Prevention in this population by screening identifies high risk 
individuals appropriate for early intervention during the asymptomatic period, before irreversible 
vision loss occurs.   Current data shows that adults with diabetes in the United States do not 
receive adequate preventive vision care. 1-3  Patients with low income and minority groups have a 
higher burden of disease but less access to care.4, 5   This program plan describes an 
interdisciplinary collaborative approach for reducing health disparities and improving access to 
eye care by offering screening services in the primary care setting with an emerging technology: 
digital retinal photography with remote interpretation.  
Geoffrey Rose’s landmark paper “Sick Individuals and Sick Populations” describes the 
identification of individuals with screening as the “high risk” strategy for prevention.  Potential 
benefits of this approach are cost effective use of resources, motivation of subject and physician, 
and a favorable ratio of risks and benefits.  A negative tendency of screening, however, is that 
those who are at the least risk of the disease are the ones who are most likely to seek care.  
Conversely, those who would benefit most from screening encounter barriers that inhibit access 
to care.6   This plan uses descriptive epidemiologic data to effectively target a population with 
health disparities, and offers a coordinated, efficient technologic solution to improve access to 
preventive eye care services. 
In the background section of this master’s paper, the evidence demonstrating the rationale 
behind digital retinal photography and telemedicine for diabetic retinopathy (DR) screening is 
discussed.  Next, the literature review provides a summary and analysis of the current evidence 
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for application of this technology in a primary care setting.  Then community based program 
plan theory is applied to describe the implementation of a screening program in the specific 
setting of Piedmont Health Services (PHS), a private non-profit federally qualified health center 
(FQHC) with approximately 3100 patients with diabetes across 6 clinic sites in central NC: 
Carrboro, Prospect Hill, Siler City, Scott (Burlington), Drew (Burlington) and Moncure. 
The evaluation plan addresses the research question:  Does placing a digital fundus 
camera with remote interpretation in primary care community clinics improve diabetic 
retinopathy screening rates?  The evaluation study design is a multiple group time series.  Pre-
implementation screening rates are gathered by chart review, and post implementation rates are 
determined for several time points after installation of the camera.  The evaluation also employs 
qualitative methods to identify areas for process improvement.   
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Background and Rationale 
Burden of Suffering 
The American Diabetes Association (ADA) reports that 7.8% of Americans (23.6 
million) have diabetes.7   Diabetic Retinopathy (DR) is a complication of diabetes and is the 
leading cause of blindness in the US among adults aged 24-75 years.  Approximately 12,000 - 
24,000 persons become blind each year from DR.8   The number of people with DR and vision 
threatening DR is high (4.1 million and 899,000, respectively), and is expected to increase   to 
7.2 million and 1.6 million, respectively, by the year 2020.9   In North Carolina, approximately 
125,000 people have DR.10   Blindness due to diabetes costs the US about $500 million annually 
in healthcare and services.11  
Natural History of Diabetic Retinopathy 
 The natural history of DR is well characterized and progresses in a predictable pattern.  
After diabetes has been present for twenty years, almost all people with DM1 (diabetes mellitus, 
type 1), and most of those with DM2 (diabetes mellitus, type 2) have DR.12 13   In the earliest 
clinically detectable stage, nonproliferative diabetic retinopathy (NPDR) is characterized by 
retinal  abnormalities including microaneurysms, intraretinal hemorrhages, and cotton-wool 
spots. Increased retinal vascular permeability may result in thickening (edema) and lipid deposits 
(hard exudates).  As diabetic retinopathy progresses towards severe NPDR, retinal vessels 
gradually close, which results in impaired perfusion and retinal ischemia signified by venous 
beading, intraretinal microvascular abnormalities and increased intraretinal hemorrhages.  
Proliferative diabetic retinopathy (PDR) is characterized by retinal neovascularization induced 
by the retinal ischemia.  These new pathological fragile vessels are prone to bleed, resulting in 
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vitreous hemorrhage.  These pathological vessels may undergo fibrosis and contraction, which 
leads to retinal traction.14   Thus, vision loss from DR results from several mechanisms.  Most 
commonly, central vision may be impaired by macular edema.  Second, bleeding from the fragile 
new blood vessels may cause preretinal or vitreous hemorrhage.  Third, fibrovascular contraction 
may cause retinal detachment or tears, often resulting in severe, irreversible vision loss. 
Diabetic Retinopathy Prevention: Screening and Early Treatment 
Risk factors for development of DR include duration of diabetes, hyperglycemia, 
hypertension, hyperlipidemia and pregnancy.  DR progression can be prevented or delayed 
through systemic control of hyperglycemia, hypertension and hyperlipidemia (secondary 
prevention).  Multicenter placebo-controlled randomized trials have demonstrated that the risk of 
developing severe visual loss from PDR and diabetic macular edema can be significantly 
reduced by laser photocoagulation administered at the appropriate stage.15-17   Since DR is often 
asymptomatic at the time treatement is required, screening is essential to avoid irreversible vision 
loss occurs (tertiary prevention).  Even patients with PDR may be unaware of the threat to sight 
until a serious hemorrhage into the vitreous occurs. 
The gold standard for diagnosis of DR consists of stereoscopic photography of seven 
standard fields on color film as developed for the Early Treatment Diabetic Retinopathy Study 
(ETDRS).18   This method is the most accurate (highest sensitivity and specificity) means of 
classifying diabetic retinopathy; however, this method is not practical for routine DR screening 
because it is costly and time consuming.  It requires specialized equipment and trained 
photographers to capture the images.  For population based identification of asymptomatic 
individuals for this common and costly disease, there is a critical need for an accurate and cost 
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effective screening method.  For diabetic retinopathy screening, the current standard of care is an 
annual (at minimum) dilated retinal exam using indirect ophthalmoscopy and slit lamp 
biomicroscopy by an eyecare professional.      
Guidelines  
 The American Diabetes Association (ADA) guidelines recommend an annual dilated eye 
exam beginning 5 years after diagnosis of DM1 and at the time of diagnosis of DM2 unless 
patients are otherwise indicated to be at low risk for DR by their eye care provider.   Similar 
guidelines have been published by the American Academy of Ophthalmology (AAO), World 
Health Organization (WHO), National Committee for Quality Assurance (NCQA), National Eye 
Institute (NEI) and Centers for Disease Control and Prevention (CDC).   
Current Level of Adherence to Diabetic Retinopathy Screening Guidelines 
Despite recommendations and public awareness campaigns from the above organizations, 
screening rates among diabetics are low, ranging from 30-75%, depending on the population and 
methods.  According to the Behavior Risk Factor Surveillance System Survey (BRFSS) in 2007, 
71.0% (95% CI 69.0 – 73.0) of adult North Carolinians with diabetes self reported that they had 
a dilated eye examination within the previous twelve months.  This is likely an overestimation of 
actual rates, since it is relies on self-report, and people without telephones or of limited English 
proficiency are underrepresented.  The National Health Interview Survey (NHIS) determined a 
baseline DR screening rate for Healthy People 2010 of 47%.19    According to NCQA’s Health 
Plan Employer’s Data Information Set, the average rate of DR screening in 2007 was 55% for 
commercial health plans, 62% for Medicare plans, and 51% for Medicaid plans.20   Similarly, a 
longitudinal analysis of Medicare claims 1991-1999 data found 56-64% had an eye exam in a 
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given 15 month period.2   An older study showed 32% of diabetics had never received an eye 
examination.3  
Barriers to Screening 
Patients with diabetes in the U.S. who have never had their eyes examined tend to be 
older, less educated, live in rural areas, and be more recently diagnosed compared to those 
receiving regular eye care.3   Cultural barriers such as language further contribute to disparities 
among minorities.21   Other studies have identified inadequate access to screening because of 
financial constraints, or geographic and transportation barriers.22   Focus groups of patients from 
a qualitative study in New Orleans identified finances as the major barrier, while focus groups of 
physicians cited poor patient education as the main reason for low adherence.  Both focus groups 
agreed that poor access to care, with wait times for an appointment as long as 1year, was a 
barrier.23   The risk of blindness from lack of screening is compounded by low adherence to 
treatment as well.  Less than 40% of patients with diabetes at high risk of vision loss receive 
recommended treatment.3  
Ethnic Minority and Low Income Groups are Disproportionately Affected 
Minority groups, especially Latinos, are at higher risk for developing DR and are less 
likely to be screened.  The National Health and Nutrition Examination Survey (NHANES III) 
study demonstrated disparities in ethnic groups for diabetic retinopathy.  Even after controlling 
for covariates, only 18.2% (95% CI 12.9 to 23.6) of non-Hispanic whites had any level of 
diabetic retinopathy, 33.4% (26.7 to 40.1) of Latinos and 26.5% (19.3 to 33.6) of blacks had 
some level of diabetic retinopathy.24  Other cross sectional studies demonstrate higher prevalence 
of DR in minority groups because they utilized more sensitive screening techniques than 
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NHANES.  In the NHANES, a single nonstereoscopic nonmydriatic fundus photograph was 
obtained from one randomly selected eye of each participant, whereas other studies utilized more 
sensitive screening techniques (3 or 7 field stereoscopic images bilaterally).    Similarly, in a 
Veterans Affairs (VA) study, risk factors such as age, time since diabetes diagnosis, and HbA1c 
did not account for the higher prevalence of diabetic retinopathy in Hispanic and black 
participants.25   In the Salisbury Eye Evaluation, African Americans were found to have an 
increased risk of visual impairment due to diabetic retinopathy compared to whites:  (17% vs 
8%).26   In the Los Angeles Latino Eye Study (LALES), almost half (46.9%) of Latinos with 
diabetes had diabetic retinopathy.27   A similar study of Hispanic adults over 40 years old in 
Arizona (Proyecto VER) found the prevalence of diabetic retinopathy to be 48%.28   All of these 
studies concur that racial and ethnic minorities are disproportionately affected by diabetic 
retinopathy.  The higher prevalence of diabetic retinopathy in Latinos primarily of Mexican 
ancestry emphasizes the public health importance of early diagnosis and management among 
Latinos.   
Besides being at higher risk for developing DR, minorities are less likely to be screened.  
In the LALES study, 65% of Mexican American patients with DM2 had not received an eye 
exam in the past year.  Latinos who had not been screened were more likely to be less educated, 
to lack health insurance, to not have had a physical exam in the past twelve months, and to have 
a glycosylated hemoglobin level ≥ 9.0%.4   Likewise, a study by Brechner et al found that 63% of 
Mexican Americans with DM2 had not received a dilated eye exam in the previous year.29   
Those at highest risk for developing DR and subsequent vision loss who would benefit most 
from screening are same people who are noncompliant to screening guidelines. 
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Low income North Carolinians have particularly low screening rates.  A study examining 
the quality of diabetes care delivered to low-income, underserved populations at fourteen North 
Carolina agencies demonstrates that the most vulnerable populations have poor access to eye 
care.  Only 6.3% of the aggregate population (n = 429) had a dilated eye exam or retinal 
photography in the past year.5   Likewise, in 55 community health centers in the Midwest 
Clinicians Network only 26% of sampled patients with diabetes (n = 2865) had an annual dilated 
eye exam.30   Data for both of these studies were gathered by chart review.  Since the authors 
relied on documentation of an eye examination, the number of exams actually performed may be 
higher.  Nevertheless, these studies identify a high risk subgroup with poor access to care. 
Existing Policy Frameworks Prioritize DR Screening 
Healthy People 2010 (US Dept of Health and Human Services) identifies diabetes as a 
target chronic condition for focusing prevention efforts to reduce the disease and economic 
burden and improve the quality of life of adults with diabetes.  Likewise, the WHO’s Right to 
Sight initiative has DR screening campaigns as part of its plan to eliminate avoidable blindness 
by the year 2020.  Objective 5-13 of Healthy People 2010 sets an achievable, objective, 
measurable for DR screening at 75%.  Much work is needed to improve the 1998 baseline 
screening rate of 47%.  This policy framework cites four reasons for the disparities in the burden 
of suffering from diabetes among ethnic groups: 
1.  Greater number of cases of diabetes.   
2.  Greater seriousness of diabetes.   
3.  Improper access to proper diabetes prevention and control programs.   
4.  Improper quality of care.  
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Healthy People 2010 categorizes the opportunities to meet the challenges of diabetes in four 
transition points in the natural history of the disease: 
1.  No Diabetes  Diabetes present (Primary Prevention) 
2. Diabetes not recognized  Diabetes Recognized (Early Diagnosis) 
3. No Care  Diabetes Care Applied (Access) 
4. Improper Care  Proper Care (Quality of Care, Secondary and Tertiary Prevention)  
 
The program plan outlined in this paper is an intervention at Transition point 4: From Improper 
to Proper Care (Quality of Care and Tertiary Prevention).   
A regional policy framework that mirrors the national objectives, Healthy Carolinians 
2010 has a useful policy framework for this program plan.31   Their objectives must meet the 
following criteria:  
 Be measurable; 
 Include measures to benefit our disadvantaged populations; 
 Emphasize individual and community intervention; 
 Emphasize the value of health promotion and disease prevention to our society; and 
 Be obtainable by the Year 2010. 
With regards to diabetic retinopathy, their objective is to increase the proportion of older adults 
with diabetes who have an annual dilated eye examination from 66.9% (1995 to 1999) to 73.6% 
by the year 2010.32    
Likewise, the North Carolina Diabetes Prevention and Control Strategic Plan 2005-2010 
lists seven lead priorities for the state public health system to address:33    
1. Social Marketing Reaching Consumers and Policy Makers 
2. Enviromental Change and Policy Supporting Healthy    Behaviors 
3. Ensuring Quality Diabetes Care 
4. Diabetes and Pre-Diabetes Benefit Coverage 
5. Access and Affordability of Screening and Care 
6. Tie Funding to Best Practices 
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7. Use Health Professionals More Effectively33  
 
 
Another policy framework is provided by the National Committee for Quality Assurance.  
Accreditation and certification from this nonprofit organization for diabetes care performance 
measures can increase participating payor reimbursements to providers who meet the quality 
performance measures.   They have as part of their diabetes management accreditation program:  
at least 60% proportion of adults with diabetes must have documented level of severity of 
diabetic retinopathy and presence or absence of clinically significant macular edema to meet the 
performance goals. 
A systematic review of interventions to promote DR screening identified a variety of 
successful interventions from 48 trials that focused on one of the following:  (1) patients or 
populations, (2) providers or practices and (3) healthcare system infrastructure and processes.34   
While a variety of interventions were shown to improve screening rates, the largest gains were in 
the studies that made system infrastructure improvements.  Interventions were less likely to 
increase screening rates if they were in rural areas, in a population with a high proportion of 
ethnic minorities, or in a large study population.  By contrast, the authors identified that health 
care systems equipped with computerized databases or multidisciplinary collaboration were more 
successful. 
Improving Screening Rates with Telemedicine 
An emerging strategy for DR screening is the use of digital retinal imaging with remote 
interpretation.  Use of telemedicine with digital retinal cameras can help overcome barriers to 
access and improve adherence to screening guidelines.  Placing a retinal camera in the primary 
care setting has the potential to lower the transportation, geographic and financial barriers that 
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are posed by an additional appointment with a specialist.  It is potentially more convenient, 
comfortable and affordable for the patient. 
The first important feature of a DR screening program using telemedicine is that it 
accurately and reliably detects disease.  A systematic review of screening and monitoring tests 
for DR by Hutchinson et al confirmed that mydriatic (with pharmacologic dilation) retinal 
photography is the most accurate screening modality.35   Likewise, studies show high correlation 
of non-mydriatic single field retinal images with the reference standard 7 field stereoscopic 
photos (kappa = 0.97).36   A review by Whited summarizes the existing literature comparing the 
accuracy of teleophthalmology screening modalities to clinic based examinations.37   He 
concluded that specificity is universally high for all DR screening methods studied, and that 
sensitivity for screening with retinal photos and telemedicine is comparable or better than clinic 
based methods for detecting and classifying DR.  Telemedicine systems that involve digital 
images that are compressed and transmitted via the internet should conform to the American 
Telemedicine’s 2004 consensus recommendations to ensure operational performance standards 
are met.38     
A few countries have implemented national DR screening programs using telemedicine: 
France’s OPHDIAT is composed of 11 screening centers, and a retrospective study showed DR 
screening rates improved from approximately 50% to 70%.39 40   The UK has also issued a 
national mandate for DR screening.  Their National Health Service reports offering screening 
with telemedicine to 85.2% of the nation’s 2,064,800 people with diabetes in 2007.41    
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In the United States, the Veteran’s Administration (VA) has the only nationally organized 
DR screening program utilizing telemedicine.  The VA has achieved efficiency and quality of 
care for its patients with diabetes that exceed that of the private sector.42   In 2005, they reported a 
biennial retinal screening rate of 79%.43    A pilot study beginning in the year 2000 using the 
Joslin Vision Network determined that teleretinal imaging provided the highest quality and most 
cost effective strategy for DR screening.44   Nationwide implementation at 17 of the 21 Veterans 
Integrated Service Networks was initiated in 2006. 
Existing policy frameworks and efforts to improve quality and coordination of care in a 
cost effective manner make screening with telemedicine an attractive solution for the private 
sector as well.  Several pilot studies demonstrate promising results. These are discussed in the 
literature review. 
 Piedmont Health Services: Reducing Health Disparities by Improving Access to Preventive 
Eye Care in a High Risk Population 
National and regional public health policy frameworks must be tailored and implemented 
locally, at the community level.  Targeting subgroups with a high prevalence of disease and low 
screening rates can reduce the population attributable risk (etiologic fraction) of vision loss from 
DR.  A systematic review conducted to assess the effect of interventions to increase the use of 
retinal screenings found that focusing an intervention on high-risk subgroups is a valid strategy 
for improving overall rates.45   Therefore, in order to address health disparities and improve 
public health using a “high risk” screening strategy in the Piedmont of North Carolina, a local 
high-risk subgroup is identified below with demographic and prevalence data.        
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The patient population served by Piedmont Health Services belongs to a high-risk 
subgroup for three distinct reasons: 
1. Poverty:  98% of PHS patients are poor, defined as having an income less than 200% of the 
Federal Poverty Level. 
2. Insurance status: 68% of adult PHS patients are uninsured. 
3. Ethnic minorities: 54% of PHS patients are Hispanic (17,943/33,141), and 19% are African 
American (6,336/33,141).  The United States Census Bureau estimates the 2004 Hispanic 
population of North Carolina at 517,617, (6% of the total population).  The prevalence of 
Hispanics with diabetes in North Carolina (7.1%) is similar to that of whites (8.2%), but 
lower than African Americans (14.6%).46  More importantly, Hispanics in North Carolina 
have less access to health care.  Compared to whites and African Americans, fewer Hispanics 
have health insurance or a personal physician, and are more likely to not see a doctor due to 
cost (see Figure 1).46  
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Figure 1 
 
Unfortunately, educational interventions do little to improve adherence to DR screening 
guidelines among low-income persons (<200% FPL) with diabetes.  The North Carolina Project 
IDEAL (Improving Diabetes Education Access and Living) Initiative sought to improve six 
evidence based diabetes care processes at locations that served primarily low-income persons 
such as community health centers and free clinics.  While the pre/post evaluation revealed large 
improvements in other measures such as glycemic control (39.6% at baseline compared to 64.9% 
at 3 year follow-up), there was little change in DR screening rates (6.3% to 7.3%).47  Therefore, 
an infrastructure improvement such as the one proposed by this program plan may be a more 
effective method to improve access to eye care.   
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In summary, a significant body of evidence from peer review literature demonstrates that 
persons with low income and minority groups, especially Latinos, African Americans, and 
Native American populations have a higher prevalence of DR and have lower screening rates.  
Existing policy frameworks designate DR screening rates as the measurable target for reducing 
health disparities and improving healthy vision among patients with diabetes.  These objectives 
can be achieved locally by implementation of a DR screening program using a digital retinal 
camera with remote interpretation at Piedmont Health Services.
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Literature Review 
Introduction 
The goal of this mini systematic review is to compile and analyze existing evidence on 
diabetic retinopathy screening programs utilizing telemedicine in primary care settings.  The 
search was guided by the following focused PICOS (population, intervention, comparator, 
outcome) question: For diabetics who receive care at a primary care center, how effective is 
diabetic retinopathy screening utilizing digital retinal photography with remote interpretation for 
detecting referable diabetic retinopathy compared to referral for a clinical exam by an eye care 
provider?  For this review, effectiveness of the intervention includes compliance with screening 
guidelines such as the impact on population screening rates and referral for treatment. 
Methods: 
A MEDLINE search was performed using the MESH search terms: “diabetic 
retinopathy” AND “screening” AND “telemedicine.”  Limits were placed to include only articles 
published in the last ten years (February 2000 – February 2010).  No limits were placed on the 
search for published language, duration of study, study design, or number of participants.  
Articles were excluded if the title or abstract emphasized other interventions such as behavioral 
interventions or automated software analysis.  Technology assessments which sought to validate 
the accuracy of a particular screening system were excluded.    For the most relevant studies, 
Google Scholar’s “related articles” feature was used to identify additional studies.  The abstracts 
were reviewed to confirm the study’s relevance.  Hand searches of citations in the included 
articles were performed to identify other relevant studies.  Full text of included articles was read 
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and the following information was summarized in Table 1: time period, study design, technology 
utilized, setting (location, population), accuracy of the screening test compared to a reference 
standard (sensitivity and specificity), proportion of ungradable images, proportion of patients 
screened, classification of diabetic retinopathy, and other secondary findings.  The studies are 
arranged in order of relevance, with the most relevant articles listed first.
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Table 1.  Summary of Selected Studies 
Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Farley et al48  
 
2001-2004 
 
Program 
description and 
evaluation: 
analysis of DR 
screening rates 
with retinal 
photography.    
Nonmydriatic 
Canon single 45° 
field with 
polaroid back.   
 
2 cameras: one  
permanently 
placed, one 
shared between 3 
clinics.  Two 
clinics were 
required to refer 
to the other 
clinics. 
Rural multisite 
(6) community 
health centers in 
northern 
Colorado  
 
65% Hispanic, 
largely migrant 
population 
 
Payor mix:  
75% uninsured 
6% Medicaid 
 9% Medicare 
10% private 
302/1,040 
(29%) had 
ungradeable 
images due to 
poor camera 
technique, 
dirty optics, 
small pupils, 
dense 
cataracts. 
314/673 (47%) at 
clinic with 
permanent 
camera 
  
261/587 (44%) 
114/297 (38%) 
130/519 (25%)  
at clinics with a 
camera ½ time;   
 
95/368 (26%), 
30/142 (21%)  
for the two 
clinics that had 
to refer patients 
to another clinic.  
= 944/2,568 
(37%) across all 
sites. 
113/1,040 
(10.9%)  of 
diabetics had  
any DR 
 
46/1,040 (4.4%)  
had “severe” DR. 
Study focused on 
whether primary 
care physicians 
could be trained 
to read fundus 
images: PCPs 
failed to refer 
35/344 (10.2%) 
patients 
identified by an 
ophthalmologist 
as needing 
referral.  Most of 
these were 
failure to 
recognize 
ungradeable 
images or 
abnormalities 
other than DR.     
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Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Taylor et al49  
 
September 2003 – 
August 2004.  
 
Retrospective 
pre/post study 
comparing 
screening rates 
before and after 
implementation of 
a digital retinal 
screening 
program. 
Mydriatic Canon 
CR6-45NM 2 
fields with 
Canon EOS D-
30 camera back, 
Dell Latitude D-
600 laptop 
connected to T-1 
Vine Hill 
Community 
Clinic, Nashville, 
TN  
 
90% Medicaid 
45% white 
45% black 
Ungradeable 
images: 1/201 
(0.5%) due to 
pupil 
misalignment.  
Ongoing 
evaluation and 
feedback of 
image 
acquisition 
produced 
consistent 
gradable 
images.   
Screening rates 
improved from 
baseline rate 
23%  to 
293/495 (59.2%) 
post 
implementation. 
104/201 (51.7%) 
screen with 
telemedicine 
were negative 
(includes  no DR, 
mild and 
moderate 
NPDR), 75/201 
(37.3%) had non-
urgent referall 
(decreased visual 
acuity, possible 
glaucoma or 
other 
microvascular 
changes). 22/201 
(10.9%) required 
urgent referral. 
Secondary 
findings also 
showed racial 
disparity: non-
whites were 
more likely to 
have sight-
threatening 
disease (14.7% 
vs 5.9%, p = 
0.02).   
   
 
King 23 
 
Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Wilson et al50  
 
1999-2003 
 
Retrospective 
pre/post study 
comparing 
screening rates 
before and after 
implementation of 
a digital retinal 
screening 
program. 
Joslin Vision 
Network:  
Nonmydriatic 
Topcon TRC 
NW-5S with 3 
stereoscopic  45° 
images +  
telemedicine to 
Beetham Eye 
Institute 
Phoenix Indian 
Medical Center 
Phoenix, AZ 
 
Indian Health 
Service: no out 
of pocket 
expenses 
 
100% Native 
American 
N/A % with annual 
examinations 
increased from 
1,455/2,910 
(50%) to 
3,051/4,068 
(75%) 
 
Rate of laser 
therapy 
increased from 
19.6 per 1,000 
(1999) to 29.5 
per 1,000 in 
2003  
N/A At a similar 
satellite clinic 
(Salt River 
Clinic) that did 
not implement 
the digital 
screening 
program, rates 
remained stable, 
near 50% over 
the same time 
period. 
Leiner et al51  
 
2006-2008 
 
Retrospective 
pre/post study 
comparing 
screening rates 
before and after 
implementation of 
a digital retinal 
screening 
program. 
Nonmydriatic 
Optos Optomap 
digital retinal 
imaging wide 
field (130°) 
scanning laser 
ophthalmoscopy 
with 
telemedicine 
University of 
Virginia’s 
primary care 
clinic: University 
Medical 
Associates 
  
>2,500 patients 
with diabetes.   
 
Most have no 
health insurance.   
18/186 (9.7%) 
had 
ungradable 
images 
Overall 
screening rate 
demonstrated 
marginal 
improvement 
from 968/2,438 
(39.7%) in 2005 
to 1,079/2,438 
(44.3%) in 2007 
29/186 (15.6%) 
with DR;  
7/186 (3.8%) had 
other retinal 
pathology. 
No show rates 
for 
ophthalmology 
appointments 
decreased from 
770/3,256 
(23.6%) in 2005 
to 664/3,807 
(17.4%) in 2007 
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Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Davis et al52  
 
2003 
 
RCT of 
telemedicine 
retinal screening 
program vs. 
standard of care 
(referral to an 
ophthalmologist). 
Nonmydriatic 
digital: Topcon 
with 
telemedicine and 
real time video 
conferencing by 
an 
ophthalmologist. 
Primary care 
setting  
 
rural, ethnically 
diverse 
population in 
South Carolina. 
N/A 23/30 (77%) 
were screened 
with retinal 
photographs on 
site vs. 4/29 
(14%) completed 
referral for a 
clinical exam by 
an 
ophthalmologist. 
N/A Small trial size 
(n = 59) limits 
reliability.  
Article is brief 
and offers few 
details on 
methods, so 
there is potential 
for significant 
selection and 
measurement 
bias.  
Massin et al53  
 
April – November 
2002 
 
Program 
description and 
evaluation of DR 
screening: 
comparison of 
referral to retinal 
photo with  
telemedicine vs 
referral for 
clinical exam. 
Nonmydriatic 
digital: Topcon 
TRC-NW6S 
with five 45° 
images + 
telemedicine 
Primary care 
Practices  
 
Paris, France 
18/358 (5%) 
had 
ungradable 
images 
309/417 (74.1%) 
were screened in 
telemedicine 
group vs. 
298/417 (71.5%) 
in standard care 
(non significant) 
23/358 (6.4%) 
had referrable 
DR (moderate to 
severe).  Patients 
with known 
history of DR 
excluded from 
study.   
Retinal 
photography 
screening was 
performed offsite 
at a single central 
location.  99.1% 
of patients who 
completed 
satisfaction 
survey were 
ready to have 
their next exam 
performed with 
the nonmydriatic 
camera.  
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Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Zimmer-Galler et 
al54  
 
October 2002 – 
March 2003 
 
Program 
description and 
evaluation 
Mydriatic, 
Digiscope ten 
fields generate 
equivalent 55° 
mosaic with 
telemedicine to 
Wilmer Eye-Tel 
Reading Center 
51 Primary Care 
Practices  
 
7 states and the 
District of 
Columbia 
295/2,771 
(11%)  were 
ungradable, 
most 
ungradable 
patients were 
>70 yo 
N/A 468/2,771 (17%) 
had DR 
Nonurgent 
referral, 71/2,771 
(3%) had urgent 
referral 
Training staff to 
use Digiscope 
required less 
than one hour. 
Conlin et al55  
 
2004-2005 
 
RCT: 448 patients 
randomly 
assigned to 
teleretinal 
imaging or 
control: are 
patients screened 
with  teleretinal 
imaging  more 
likely to have a 
dilated eye exam 
within the next 12 
months compared 
to usual care 
Joslin Vision 
Network:  
Nonmydriatic 
Topcon TRC 
NW-5S with 3 
stereoscopic  45° 
images +  
telemedicine to 
Beetham Eye 
Institute 
Department of 
Veterans Affairs 
(VA) Boston 
Healthcare 
System 
 
98% male 
88% white 
10% African 
 american,  
mean age: 67 yo 
80/223 (36%) 
of patients had 
ungradeable 
images. 
Average 
ungradeable 
pupil 
diameter: 3.2 
vs 4.1 mm for 
gradable 
images. 
194/223 (87%) 
vs. 173/225 
(77%) p < 0.01 
had a 
documented 
followup dilated 
eye exam within 
the next 12 
months. 
teleretinal 
imaging graded 
patients as 
having more DR 
compared to 
followup dilated 
eye exam ĸ = 
0.42 (moderate 
agreement) 
Patients reported 
high level of 
satisfaction with 
teleretinal 
imaging (1.1 on 
a scale of 1-4, 
with 1 being 
very satisfied).   
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Study Technology Setting Ungradeable 
Images 
Referral /  
% Screened 
Diabetic 
Retinopathy 
Comments 
Cavallerano et al56  
 
June 1999 – 
October 2000 
 
Program 
description and 
retrospective 
evaluation 
Joslin Vision 
Network:  
Nonmydriatic 
Topcon TRC 
NW-5S with 3 
stereoscopic  45° 
images +  
telemedicine to 
Beetham Eye 
Institute 
Joslin Diabetes 
Center 
Outpatient 
Intensive 
Treatment 
Program:  3.5 
day 
multidisciplinary 
comprehensive 
diabetes 
counseling and 
evaluation 
 
Boston, MA 
 
57% MA 
residents 
53% DM1 
 
 
68/525 (13%) 
had at least 
one 
ungradable 
image.  50/61 
(82%) of 
patients with 
ungradeable 
images had 
findings that 
would have 
resulted in 
referral. 
 
JVN diagnosis 
agreed with 
clinical exam 
by retina 
specialist 
within one 
level of DR 
for  478/ 535 
eyes (89.3%) 
268/525 (51%) 
patients referred: 
due to DR 
(17.1%), other 
disease (25.9%), 
ungradeable 
images (12.9%) 
or >12 months 
since last exam 
(11.4%) 
None (43.3%) 
Mild (30.7%)  
Moderate(8.3%)   
Severe (5.9%) 
Very Severe 
(3.9%) PDR < 
HR (2.8%) PDR 
> HR (2.1%) 
DME (3.6%) 
CSME (5.4%) 
High level of 
referral included 
all patients with 
no exam within 
12 months or 
referral for other 
lesions found.  
 
Stereoscopic 
imaging also 
allows accurate 
assessment of 
DME and 
CSME.   
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Results: 
The MEDLINE search strategy returned 82 articles.  Nine articles were identified which 
met search criteria.  No articles were found that addressed long-term patient centered health 
outcomes such as blindness or loss of visual acuity.  Only one of the articles evaluated the effect 
of screening on treatment.  Six studies directly addressed the implementation of the program’s 
effect on screening rates for the diabetic population.  Two studies took place in the setting of 
community health centers.    
All six studies which evaluated the proportion of the population screened showed 
increased screening rates with implementation of a digital retinal imaging system.  On average, 
screening rates improved by about 25% (range = 3%-63%) when compared to preimplementation 
screening rates or to a control group; however, there was significant heterogeneity in study 
design, methods used for measurement, populations, and a wide range of improvement among 
studies. 
Farley et al.: Salud Family Health Center 
Farley et al. is the most relevant study for this program plan and evaluation, since it was 
conducted at a multisite community health center serving a largely uninsured Hispanic 
population, similar to Piedmont Health Services.  This is the only study that evaluated the impact 
on screening rates of resource sharing across multiple sites.  Two cameras served six sites: a 
camera was permanently installed at one clinic, and the second camera was transported between 
three clinics so that it was available twice yearly at each site.  Patients from the other two clinics 
had to be referred to one of the clinics with a camera.  As expected, the clinic with the permanent 
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camera achieved the highest screening rate (47%), while the 3 clinics that shared a camera had 
lower rates (44%, 38% and 25%), and the two clinics who referred their patients included the 
lowest screening rates (26% and 21%).  The authors explain that the wide variation in screening 
rates for clinics with intermittent camera availability is due to lack of standardization in 
procedures used by the various clinics: some clinics were more aggressive than others in 
recruiting patients and using the “no-missed-opportunities approach.”  Interviews with clinicians 
suggested that the intermittent nature of the camera availability made it less likely for them to 
remember to refer patients for screening.  Although this study did not evaluate 
preimplementation screening rates, they estimated historic screening rates in this population to 
be less than 10%.   
They also described their method of recruitment.  First, clinicians were informed of the 
program and encouraged to schedule their patients for a screening appointment.  They also sent 
letters to their patients encouraging them to schedule retinal screening appointments.  Finally, in 
clinics where the camera was available, clinicians offered walk-in appointments at the 
conclusion of clinic visits.  One of the other strengths of this article is that it included the costs of 
the program: they spent $25,000/camera ($50,000 for two cameras) and $30,000/year/camera 
operator. 
One study limitation is how they determined screening rates:  patients were considered 
screened if they had any photographs taken during the 3-year study period, regardless of whether 
or not the photographs were interpretable.  In other words, patients could be counted as screened 
even if their photograph was ungradeable due to poor image quality (misalignment, small pupil, 
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opacity, out of focus).  This is not a patient-oriented outcome; rather, it is a measure of the 
program’s activity. 
Another interesting part of this study was the relatively large number of ungradeable 
images.  Compared to the Vine Hill Study, where only 1/201 (0.5%) patients had images that 
were deemed ungradeable, nearly one third of these patients had ungradeable images (302/1,040 
= 29%).  In the discussion section, the authors disclose that since the end of the study period, 
they changed their protocol to use mydriatic drops as needed, and their inadequate photo rate is 
now less than 1%.   
Farley’s study would be strengthened if they had included more information about patient 
demographics, particularly age.  Specifically, the number of patients with any level of DR 
113/1,040 (10.9%) is low compared to the landmark prevalence studies LALES27  and Proyecto 
VER,28  which demonstrated a DR prevalence of 47% and 48%, respectively, in Latino 
populations over the age of 40.  Since Salud Family Health Center’s population is largely 
composed of migrant workers, the discrepancy is likely due to a younger patient population.   
Several lessons learned from this study can be applied for program implementation and 
evaluation.  First, clinics with a permanent camera achieve higher screening rates.  Second, the 
number of ungradeable images can be drastically reduced with use of dilating drops.  Third, to 
best evaluate the impact of a program, some evaluation has to be done before implementation so 
that a measurement can be made and compared to the baseline.  Finally, although the authors 
conclude that PCPs can be trained to interpret fundus photographs, I believe this is an 
unnecessary compromise.  If the PCPs missed 10% of retinal pathologies compared to an 
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ophthalmologist reading the same images, why not use a telemedicine approach and transmit the 
images to an expert via the internet?  The authors concede that, “It would be difﬁcult to develop 
a curriculum that could address all of the myriad abnormalities found in retinal examinations 
unrelated to diabetic retinopathy.” 
Taylor et al: Vine Hill Community Clinic 
The Vine Hill study was conducted in the setting of a single community health center 
serving a largely indigent population.  The preimplementation baseline DR screening rate was 
23%, despite prior initiatives to improve rates consisting of provider education and clinical 
reminder systems.  After making digital fundus screening available, the screening rate improved 
to 59.2%.  This still falls below the goal of 75% established by Healthy People 2000, but it 
shows that enormous improvement can be made in one year.  The quality of evidence in this 
article is excellent, given the explicitly described methods and strong study design.   
The authors of the Vine Hill Study identified visual acuity testing as an important 
component of any good fundus photography screening program, and they screened all patients 
using a desktop visual acuity testing machine (Optec 800X).  Their protocol led to nearly half of 
all patients to be referred to ophthalmology (48.3%).  Decreased visual acuity accounted for the 
majority (50/97) of all referrals, and only 1/201 patients screened had an ungradeable image.  In 
the discussion section, the authors attribute their low failure rate (ungradeable images) to 
pharmacologic pupil dilation.  
The outputs of their program were precisely measured with the assistance of electronic 
health records.  One issue that was not addressed by the authors, however, is why so many 
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patients opted out of the screening: for the 495 diabetics seen during the year, only 201 (40.6%) 
elected to have screening performed. 
Wilson et al: Phoenix Indian Medical Center 
Evaluation and measurement of short term program outcomes (treatment by laser 
photocoagulation) set this study apart from the others.  The Indian Health Service’s EMR was 
used to measure annual screening rates before and after installation of the Joslin Vision Network 
(JVN).  The screening rate increased from 50% to 75% over 3 years.  Ancillary data showed a 
steady screening rate of about 50% over the same time period at a satellite clinic that did not 
implement the intervention, which further bolsters the conclusion that the improvement in 
screening rates can be attributed to the addition of the retinal imaging technology.  Likewise, the 
number of people treated for diabetic retinopathy increased from 19.6 per 1,000 diabetics in 1999 
to 29.5 per 1,000 diabetics in 2003; however, the rate of treatment for diabetics screened 
remained stable: 39.2 per 1,000 screened were treated in 1999 vs. 39.3 per 1,000 screened in 
2003.  Thus, the increase in preventive treatment is due to improved surveillance. 
Although the study had excellent internal validity, generalizability is limited because the 
Indian Health Service (IHS) operates the Indian Medical Center and the population of Native 
Americans receive care with no out-of-pocket expenses.  The authors claim they are comparable 
to general population since they have similar baseline screening rates to the general population 
(about 50%), and describe the chief barrier to adherence as transportation. 
Leiner et al: UVA Internal Medicine Clinic 
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Leiner et al’s model used a slightly different technology for screening.  Whereas other 
systems use a digital camera to acquire an image of the retina, Optomap utilizes a confocal 
scanning laser that captures a wider angle (130°) to include more of the peripheral retina.  This 
seems to be a reasonable technology, but it is newer and less proven.  Although a trial comparing 
the Optomap to digital fundus photography has shown similar sensitivity and specificity for DR 
screening,57  it has not been validated against the gold standard stereoscopic 7 field ETDRS 
photographs.  Implementation of this screening method resulted in a small but statistically 
significant increase in screening rates from 39.7% in 2005 to 44.3% in 2007 (p = 0.005).  The 
authors attribute the relatively low increase in screening rates to, “staff training and technical 
issues.”   
Leiner’s evaluation is unique because they measured the program’s impact on no-show 
rates for ophthalmology referral appointments and found slight improvement from 17.4% in 
2005 to 23.6% in 2007.  
Davis et al.: Primary Care in Rural South Carolina 
  Davis’s randomized controlled trial found that 23/30 (77%) of patients assigned to a 
telemedicine retinal screening program obtained an eye examination compared to 4/29 (14%) of 
patients assigned to usual care, who were simply reminded to schedule an eye examination with 
their eye care provider.  This article was brief and did not provide a detailed description of the 
program, or report any other results.   
Massin et al.: Primary Care Clinics and a Central Screening Site in Paris, France 
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Massin’s study evaluated whether a centralized DR screening location could serve a 
larger population.  A network of primary care clinics referred their diabetic population to a 
designated screening site.  The authors demonstrated that similar screening rates could be 
achieved using a centralized retinal photography screening program (74.1%) compared to usual 
care (71.5%)   Secondarily, they evaluated patient satisfaction towards that screening method and 
found that 99.1% of patients screened were ready to have their next exam performed with a 
nonmydriatic camera. 
The remainder of the studies did not measure screening rates in the population; the 
primary outcome measured was the level of DR detected and the reasons for referral.   
Zimmer-Galler et al.: Digiscope in 51 Primary Care Offices  
This program description and evaluation measured the referrals resulting from screening: 
17% had non-urgent referral, 3% had urgent referral, and 11% were referred for ungradeable 
images.  The authors claim that referral for ungradable image was not a drawback, “because 
older individuals are at higher risk for ocular pathology and should be seen by an 
ophthalmologist even if they do not have diabetic retinopathy.”  A potential weakness of this 
study is the financial conflict of interest:  the author is entitled to a share of sales royalty for 
Digiscope cameras, owns stock and is a paid consultant for EyeTel Imaging. 
Conlin et al: Veterans Affairs, Boston 
Conlin’s study asked the question: does addition of teleretinal imaging increase the rate 
of adherence to clinical dilated exams?  The authors took the approach that teleretinal imaging is 
not a confirmed alternative to dilated eye exams, and that many patients with DM still require 
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dilated eye exams by an ophthalmologist annually.  The authors credit the educational aspect of 
their program for the increase in adherence to dilated eye exam within 12 months (87%) 
compared to usual care (77%), p <0.01.  After completing the imaging protocol, the imager 
educated the participant about the importance of optimal blood glucose and blood pressure 
control and demonstrated to the participant the basic anatomical structures of the ocular fundus 
(optic nerve, macula, retinal blood vessels).  In this model, the screener also acts as a care 
manager, contacting patients and facilitating follow-up visits.  The educational component of the 
imaging encounter reinforced the need for regular eye care.  This study has limited external 
validity, since the population was mostly older white men.  As patients age, they develop 
cataracts (lens opacities), and their pupils become smaller.  These factors contributed to a large 
number of ungradable images (36%).  Similar to Zimmer-Galler, Conlin et al further justify the 
high rate of ungradable images with the argument that 56/80 (63%) of those with ungradable 
images had one or more ocular findings that warranted referral: cataracts (40%), glaucoma 
features (23%), macular degeneration (16%) nevus (4%) and emboli (2%). 
Cavallerano et al: Joslin Diabetes Center Outpatient Intensive Treatment Program 
External validity of the study is limited because much of the study population was 
designated as having DM1 (53.1%) based on the operative definition of insulin use and diabetes 
onset prior to age 40.  The authors concluded that the low number of patients referred for retinal 
specialist examination who did not have eye disease on examination support its value in follow-
up and use in assessing patients with diabetes for eye examination.    
Discussion 
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  While studies evaluating detection of diabetic retinopathy in the community using 
nonmydriatic cameras go back as early as 1991, new technologies have constantly been adopted 
in an effort to improve the quality, convenience and efficiency while lowering cost.  In the 1991 
study by Higgs et al, 34% of patients had unreadable images.  Therefore, while the study was 
able to increase detection of DR in a rural population, it did a poor job of ruling out disease and 
required a high referral rate.
58 
  More recently, the transition to digital imaging and the 
transmission of acquired images over the internet have made a complex multistep process more 
streamlined.  User-friendly image capture devices that can be operated by clinic staff in a 
primary care setting have the potential to dramatically improve DR screening rates; however, 
some programs show only marginal improvement. 
One issue that most studies addressed is whether or not to routinely employ 
pharmacologic dilation (mydriasis) for patients undergoing screening.  Of the nine studies 
included in this review, only two (Taylor et al and Zimmer-Galler et al) utilized mydriasis.  The 
advantages of comfort and convenience with a non-mydriatic approach must be balanced with 
the disadvantages of potential lower quality and higher proportion of ungradeable photos when 
compared to mydriatic photographs.  Other studies show the proportion of ungradable photos 
using nonmydriatic photographs range from 10-35% and drop to 2-7% when papillary dilation is 
used.59, 60  Farley et al report in the discussion section that since the end of the study period, they 
changed their protocol to use mydriatic drops as needed, and their inadequate photo rate is now 
less than 1%.  Some screening programs shy away from dilating patients because the very small 
risk of acute angle-closure glaucoma that is associated with use of dilating drops; however, a 
systematic review of the topic revealed no cases of acute glaucoma from the use of  tropicamide 
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alone.  The risk of inducing acute glaucoma with tropicamide and phenylephrine combined is 
about 1 in 20,000.61  Applying these lessons to this program plan, the best approach is to first 
attempt to acquire images without mydriasis.  In case of poor image quality due to small pupils, 
the screener may use tropicamide for mydriasis, and reattempt image acquisition. 
The percent of patients whose images were ungradeable was addressed in most studies.  
At one end of the spectrum, Conlin et al report 80/223 (36%) of patients with ungradeable 
images.  They found a significant correlation between smaller pupil sizes in ungradable vs. 
gradable images (3.2 mm ± 0.1 vs 4.1 mm ±0.1, p <0.001), and attributed their high rate of 
ungradeable images to the rigorousness of the image grading protocol, “which used much higher 
standards than are typically applied in a clinical setting.”  A weakness in this argument is that the 
qualities of a good DR screening exam should be to identify new cases of referable DR.  The 
Joslin Vision Network (JVN) system appears to shift the balance of screening towards diagnostic 
evaluation at the expense of time, convenience and flexibility that characterize successful 
screening programs.   
This leads us to ask if the additional information gathered by seven stereoscopic images 
per eye in the more rigorous JVN protocol are worth sacrificing convenience and simplicity?  
For this program plan, a single 45° image is recommended, since it provides sufficient 
information for DR screening.  Single field nonmydriatic imaging has shown excellent 
agreement (kappa = 0.97) with the diagnostic reference standard.36 .  Furthermore, this 
nonstereoscopic approach has the ability to identify most cases of clinically significant macular 
edema.  Any patient with hard exudates within one disc diameter of the macula can be identified 
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as having a marker for macular edema.  Bresnick et al showed this strategy has a sensitivity of 
94% for detection of clinically significant macular edema.62      
The rate of referral varied from about 10-20% for most studies.  The dominant reason for 
referral was diabetic retinopathy; however, other ocular pathologies were identified such as age 
related macular degeneration, lens opacities, and features suggestive of glaucoma. 
The evidence summarized in this literature review demonstrate that significant 
improvements in DR screening rates can be made by implementing a program in the primary 
care setting.  These studies also raise other important issues, including mydriasis, the number of 
photographic fields appropriate for screening, and referral rates, but do not address the issues of 
long term health outcomes or financial sustainability. 
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Program Plan 
Overview 
This plan describes a program for diabetic retinopathy screening at Piedmont Health 
Services (PHS), a federally qualified health center (FQHC) with six clinic sites in central NC: 
Carrboro, Prospect Hill, Siler City, Scott (Burlington), Drew (Burlington) and Moncure.  This 
document briefly addresses the context, theory and implementation of an innovative intervention 
that seeks to prevent vision loss among the diabetic population of PHS. The cornerstone of the 
program is to improve patient adherence to screening guidelines among a population that has 
poor access to specialist care (annual dilated eye exams by an ophthalmologist).  Placing a digital 
retinal camera in the primary care setting will reduce barriers to access and increase the 
proportion of patients screened in this population.   In this manner, patients can be identified in 
the asymptomatic stage of diabetic retinopathy, and timely referral and treatment substantially 
reduces the risk of vision loss.  
Context of the Program plan  
Overall, the context of the program plan can be characterized as welcoming, but guarded due 
to limited financial resources required for the initial investment.  An agricultural analogy would 
be that the program seed is falling on fertile soil, but a heavy rain of dollars is required before the 
program can begin to take root and grow. 
The stakeholders are interested.  Piedmont Health Services (PHS) is “sold on the idea,” they 
simply lack the funds to purchase the camera.  Their organizational culture is aligned with the 
objectives of the program plan. They are well suited to serve the needs of the community and 
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have adapted over the years to accommodate a diverse population with a significant proportion 
of minorities. 
 Likewise, studies show that patients prefer screening with a nonmydriatic camera in the 
primary care setting compared to visiting an ophthalmologist.  Results of a satisfaction survey in 
a prospective cohort study in France showed preference for the shorter duration of testing (96% 
compared to 82% for controls, p <0.001) and decreased visual impairment induced from 
screening (86% compared to 66% with dilated exam, p<0.001).  Indeed, 99.1% of patients from 
the experimental group were ready to have their next annual screening exam performed with a 
non-mydriatic camera.53  
Awareness about diabetes in general is already high among the public; however, more 
patient education about preventing complications from diabetes is needed.  This program plan 
will create a new opportunity for education by the staff at the time of screening.  Patients will be 
able to see the digital retinal image on the output monitor immediately after it is taken. 
Considering the current economic climate, competing priorities are definitely an issue 
with PHS. In general, a wide range of needs must be met with funding from a small handful of 
sources.  Therefore, priorities must be designated so the most important needs are allocated 
resources as determined by both PHS and potential funders.  The priorities of this program are 
consistent with national, state and local priorities as outlined by Healthy People 2010, as well as 
Healthy Carolinians 2010.19, 31  
Goals and objectives 
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GOAL:  To prevent vision loss among persons with diabetes. 
SHORT TERM OBJECTIVES:  
 By January 1, 2011, a nonmydriatic digital retinal camera will be acquired and installed 
in one clinic location 
 By January 1, 2011, at least 2 staff members will be trained in acquisition of digital 
retinal images  
 By January 31, 2011, at least 2 staff members will be proficient at acquiring images, with 
a 90% success rate  
 By December 31, 2012, 50% of adult diabetes patients at Piedmont Health Services 
(Moncure site) will be screened for diabetic retinopathy in the previous 12 months. 
 
LONG TERM OBJECTIVES:  
 5 years after initiating the program, 75% of adult diabetes patients at Piedmont Health 
Services will be screened for diabetic retinopathy in the previous 12 months. 
 5 years after initiating the program, 90% of patients found to have vision threatening 
retinopathy will be referred and appropriately treated by a specialist. 
 10 years after initiating the program, 50% fewer patients will have vision loss due to 
diabetic retinopathy, compared to the previous 10 years. 
 10 years after initiating the program, total practice costs (including initial capital costs) 
will be offset by revenue generated. 
 
Relevant program theories 
The diffusion of innovations is the most relevant program theory to apply to this program 
plan.  The central tenet behind this theory as defined by E. M. Rogers is, “the process by 
which an innovation is communicated through certain channels over time among the 
members of a social system.”63 In this program we promote the innovation of screening in the 
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primary care office with retinal imaging, rather than traditional screening by an eye 
specialist.  According to the diffusion of innovations theory, there are 5 benefits of an 
innovation which influence the degree it will be adopted, and if it will ultimately become 
institutionalized: relative advantage, compatibility, complexity, trialability and observability 
(see Table 2).64  Analyzing the elements of the program through this theory helps to identify 
and maximize its novel benefits.  For example, in order to maintain the relative advantage for 
this screening program, the service must be more accessible and cost less than traditional 
screening. 
Table 2. Attributes of an Innovation 
Attribute Question Relevance 
Relative 
Advantage 
Is the innovation better than 
what it will replace? 
Yes, improved convenience for 
patient, improved access, 
decreased cost, more integrated 
care. 
Compatibility 
Does the innovation fit with 
the intended audience? 
Yes, patients prefer imaging 
over screening by clinical 
exam.  Technology 
assessments by AAO65  endorse 
retinal imaging for screening.
6
 
Complexity 
Is the innovation easy to use? Camera can be operated by 
staff with minimal training. 
Trialability 
Can the innovation be tried 
before making a decision to 
adopt? 
Contingent on securing 
necessary equipment.  
Observability 
Are the results of the 
innovation observable and 
easily measured? 
Yes, proportion of patients 
screened can be determined by 
records review. 
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The process of adopting new technologies follows a bell curve with the following categories: 
innovators (the first 2.5%), early adopters (next 13.5%), early majority adopters (next 34%), late 
majority adopters (next 34%) and laggards (final 16%).  At the organizational level compared to 
other United States primary care providers, the program participants are innovators, since they 
are on the cutting edge of adopting a new technology to enhance the quality of their health 
services.  On a global scale, however, the United States falls into the early adopters category, 
lagging behind innovators such as the UK and France who have instituted national screening 
programs using retinal imaging. 
Secondarily, we can apply the CDC’s sociocultural environmental theory to demonstrate how 
this program plan seeks to reduce health disparities.  The sociocultural environment framework 
was created by the CDC’s Task Force on the Guide to Community and Preventive Services (see 
Figure 1) to demonstrate how to target interventions to reach populations, not just individuals.66   
In this program, the population that stands to benefit most is made up of those with diabetes and 
poor access to specialist care who attend the federally qualified health center (FQHC).  This 
group is largely made up of an underserved low income Hispanics with poor access to eye care 
providers and a high burden of suffering of a preventable disease.  This program aims to create 
healthy populations at strategic intervention points 5 (opportunities for education and developing 
capacity) and 6 (health promotion, prevention and care opportunities).  Patient education occurs 
at the time of screening.  The captured retinal images on the output screen can serve as a visual 
learning tool to assist patients in understanding the pathophysiology and asymptomatic nature of 
diabetic retinopathy.  Furthermore, the interaction with the screener offers the patient an 
opportunity to learn more about visual complications of diabetes.   Finally, with regards to 
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strategic point 6 in the CDC’s sociocultural model, this program seeks to improve access to 
preventive services for a minority group with low screening rates. 
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Figure 1.  Sociocultural Environment Logic Framework 
Guide to Community Preventive Serv ices: Sociocultural Environment Logic Framework 
DETERMINANTS 
SOCIETAL RESOURCES 
concerns t he p resence 
of essentia l resou rces 
while EQUITY and 
SOCIAL J USTICE 
concerns the distri bu tio n 
of t hose resou rces 
within the populatio n 
IMMEDIATE OUTCOMES 
* links 1-6 indicate strategic 
points fo r interventio n 
HEALTH OUTCOME 
A pathway that will not be examined 
' 
' 
' 
' 
' 
' -------------------------------------------~ 
Source: Institute of Medicine. Speaking of Health: Assessing Health Communications Strategies for Diverse 
Populations. Washington, D. C.: National Academies Press, 2002. 
   
 
King 45 
 
Program Implementation  
The first step in implementing the diabetic retinopathy screening program will be to develop 
and document a protocol for the patient flow.  Existing handbooks for DR screening can be 
tailored for PHS.67, 68   Besides serving as a set of instructions for acquiring the images, the 
protocol should determine a schedule for rotating the resources among the separate branches of 
PHS.  Since PHS has six separate sites, scheduling and transporting the equipment will need to 
be carefully coordinated with the staff at all the sites.  A well documented plan must be 
disseminated to the other stakeholders at PHS so they have an opportunity to contribute from its 
inception.  Specifically, the physicians will be more likely to refer their patients for screening if 
they approve of the overall design of the protocol.  Likewise, the scheduling and referral staff 
need to be aware of when the screening resources will be available at their site. 
Next, one of the most critical steps in the implementation plan is advertising and hiring a 
new staff member to actually conduct the screenings.  This person will serve as a champion of 
the screening process from start to finish.  Ideal traits for a candidate are excellent organizational 
and communication skills, and a willingness to adapt.  For a screening program with multiple 
locations, there has to be some constant factor that keeps things moving smoothly.  The screener 
will serve that vital role. 
Ideally, the camera should be purchased before the screener is hired so that training can 
occur right away.  The timeline assumes that outside grant funding has already been secured in 
order to purchase the retinal camera, and a specific model has been selected.  At the same time 
the camera is being installed and the screener is being trained, it is time to start advertising the 
program to the patients.  In this program, posters and educational brochures (see Appendix) will 
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assist the physicians in educating their patients about the rationale for screening. Next, it is time 
to deliver the program.  Screening will take place per the protocol developed and revised by the 
stakeholders at the six PHS locations.  In order to meet the goal of screening 75% of 
approximately 3100 patients with diabetes at PHS, 2325 patients will be screened in a given 
year.  If screening is performed on 200 days/year, that translates to 11.6 patients/day.  Inevitably, 
there will be some challenges the protocol did not anticipate early in the process, so the screener 
will need the support of staff at the given location, as well as from the medical director to resolve 
problems. 
After the images are acquired, they are electronically transmitted to an expert reader who 
grades the image and provides a recommendation for follow-up.  The reader sends this 
information in a report back to PHS medical records, who places the report in the patient’s 
electronic medical record and mails a copy to the patient’s home address. 
Sustainability 
Regarding sustainability, it is an objective for this program to be able to fund itself in the 
long term; however, even after purchasing the initial equipment with grant funds, the revenues 
gained from billing for this service may not offset the annual operating costs of the program.  For 
the PHS population over the age of 20, 68% are uninsured, 8% have Medicaid, 8% have 
Medicare and 16% have private insurance.  If we apply these proportions to PHS’s 3100 patients 
with diabetes (target audience), then we can generate a rough estimate for potential revenues (see 
Table 4).  In North Carolina in 2010, CPT code 92250, Fundus photography with interpretation 
and report, is reimbursed by Medicare for $62.95 ($41.28 for the technical component of 
acquiring the image, and $21.67 for the professional component of interpreting the image). 
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Reimbursement by other payors was assumed to be $0 for self-insured and Medicaid (free 
service to those without insurance), and 110% of Medicare for private insurers.  Medical 
necessity is designated by ICD-9 250.XX codes related to diabetes.  Other ocular or systemic 
diseases may justify use of the camera for retinal screening, the most common are listed in 
Appendix B. 
Another issue that must be considered is the sustainability for the treating physician 
(ophthalmologist).  This program seeks to identify a subgroup of patients with low income and 
send them to specialists using existing referral patterns, but does not address funding or 
reimbursement for treatment.  Financial assistance including charity care at safety net hospitals 
such as UNC discount a portion of the facility costs, but does not cover physician services fees.  
Other resources that provide financial assistance for preventive eye care are listed at Prevent 
Blindness of North Carolina’s webpage (see Appendix C), but these are limited to children or 
U.S. citizens.    
Besides financial sustainability, the project must have key champions who take clear 
responsibility in maintaining and improving the program.  The medical director of PHS will 
assume oversight of the program and reviewing its process improvement.  It is critical that the 
medical director of PHS has strong buy-in and feels that this is a worthwhile to direct the 
necessary resources for delivering the program.  There must also be another key champion who 
oversees the day to day operations of the screening and shepherds the process through on a 
regular basis.  Since screening is a complex process and requires technical equipment, the 
process will inevitable fail without a champion who takes personal responsibility for managing 
the day to day operations.  The organizational chart (Appendix A) demonstrates the relationship 
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between the parties involved.  This model assumes that the administrative tasks involved with 
this program can be absorbed by the existing personnel and resources.  In other words, the 
medical records staff will have additional information to include in the patient record, and the 
appointment secretary will be able to schedule screening appointments without additional 
expenses.  Finally, strong internal communication among all relevant parties at PHS will be 
required so that everyone understands and accepts their new roles and responsibilities. 
 
Figure 2.  Timeline for Program Implementation 
Activity 
2010 2011 2012 
7 8 9 
1
0 
1
1 
1
2 
1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1 2 
Develop screening 
protocol 
X X                   
Advertise for 
personnel 
  X X                 
Acquire and install 
camera (Moncure) 
   X X                
Hire personnel 
    X                
Train Personnel 
     X               
Advertise the 
program 
     X               
Deliver the 
program 
      X X X X X X X X X X X X X X 
Conduct process 
evaluation 
       X     X      X  
Conduct outcome 
evaluation 
                  X  
Analyze outcomes, 
produce reports 
                  X  
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 Table 3.  Budget 
Budget 2010-2011 Equipment: nonmydriatic digital retinal camera $30,000 
Personnel Salary: 
One full time staff member to act as retinal 
screener and coordinator 
$30,000 
Personnel Benefits: 
(27% of salary) 
$8,100 
Technology Support for initial set up of multiple 
sites 
$2,000 
Transportation Costs for screener ($0.50/mile) $2,000 
Medical Records: reports to patients $2,000 
Total $74,100 
Budget 2012 Equipment: $0 
Maintenance: 
Included in 5 year purchase cost of camera 
$0 
Personnel Salary:  
One full time staff member to act as retinal 
screener (3% cost of living increase) 
$30,900 
Personnel Benefits 
(27% of salary) 
$8.343 
Transportation Costs for screener ($0.50/mile) $2,000 
Medical Records: reports to patients $2,000 
Total $43.243 
 
Table 4.  Estimated Annual Revenue Generated from Screening 
Payor (%) # of 
diabetics 
% 
screened 
Anticipated 
Number 
Screened 
Reimbursement Totals 
        
Uninsured 68% 2093 0.75 1570  $                   -     $       0                    
Medicaid 8% 244 0.75 183  $                   -  $       0 
Medicare 8% 232 0.75 174  $              41.28  $  7,193.22  
Private 16% 498 0.75 373  $              45.41  $ 16,953.40 
        
Total Patients  3068 0.75 2301   $  24,146.62            
   
 
King 50 
 
Table 5:  Logic model  
Resources/Inputs Activities Outputs 
 
Short & Long 
term Outcomes 
Impact 
Funding source 
for capital 
improvement 
(purchase retina 
camera) 
Planning 
resources 
PHS staff for 
coordinating 
appointments and 
capturing images 
PHS Clinicians 
Technical 
support for 
network 
connectivity 
Trained retina 
image reader 
Ophthalmologist 
for referral 
Data 
Acquire  and 
install camera 
Develop and 
implement 
screening 
protocol 
Train staff to 
screen patients 
Screen patients 
Educate patients 
Readers grade 
images and 
develop 
treatment plan 
Refer patients 
needing  
treatment to 
appropriate 
specialist 
 
Higher 
compliance with 
screening 
guidelines (% 
screened) 
More DR 
detected 
Referrals 
completed for  
those needing 
treatment 
(appointment 
attended and 
report returned 
and included in 
EMR) 
Patients 
informed of 
retinopathy 
status 
Increased 
awareness of 
vision 
complications to 
diabetes for 
providers and 
patients 
Increased 
awareness by 
patients of how 
to prevent vision 
loss from 
diabetes 
Increased access 
to preventive 
services. 
Increased 
referrals for 
treatment 
Less vision loss 
among patients 
with diabetes 
Improved health 
for persons with 
diabetes 
Diabetes care 
quality 
performance 
initiatives 
achieved 
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Evaluation Plan 
Rational and Approach to the Evaluation 
The proposed DR screening program is complex, having several dependent steps that require 
cooperation between multiple parties.  A review of the implementation is needed to ensure 
completion of the activities in order to reach everyone in the target population.  Likewise, an 
evaluation should determine if objectives are being met in order to justify the allocation of time 
and resources to the DR screening program.   
Program evaluation is a necessary process to improve a program.  By comparing outcomes 
(DR screening rates) between the six implementation sites (and even among patients of different 
providers), we can then attempt to identify elements that engender success at the best sites, as 
well as harmful or missing elements at the sites with lower screening rates.  Finally, because this 
program relies on an outside funding source for the initial equipment purchase, an evaluation 
will be an essential component of the grant.  Funders want to see results to verify their money 
was well spent.  Finally, a program evaluation will gather data that can be used to show the 
success of the program for publication and future dissemination of the program to other sites.    
Although an external evaluator offers an unbiased perspective, an internal evaluator is 
suitable for this program.  The reliability and validity of the objective data gathered from the 
electronic medical record for the key outcome measurement (DR screening rates) are dependent 
on explicitly detailed systematic methods.  Therefore an internal evaluation by PHS staff, 
executed by the Quality Director and analyzed by the PHS chief medical officer allows an 
appropriate level of familiarity with the sites and the staff without significant danger of having 
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biased results, as long as the methods for data entry remain constant over time.  The evaluators 
will need access and fluency in navigating PHS’s electronic medical records system.  The 
evaluator will also need to be able to identify and communicate well with the stakeholders who 
are responsible for implementing the activities of the program.  Specifically, the chief medical 
officer of PHS could present the data to the clinicians in a meeting or elicit feedback from a 
clinician one-on-one. 
Some of the key questions the stakeholders will have: 
Providers:  How program implementation change my workflow, or amount of time required for a 
visit with my patient? 
Patients: What are the risks/benefits of screening for DR?  How much does this cost? 
CMO:  Will this improve the quality of care delivered to our population? 
CEO: What are the costs and revenues of this program? 
Funding agency: Does this improve the health of the population?  Address health disparities? 
Engaging the stakeholders before implementation of the program will be critical for ensuring 
buy-in and approval of the participants. 
A potential challenge the evaluator will encounter is ensuring the data is accurate.  If the 
information is gathered from existing electronic medical records which is input from the 
providers, how can they be sure the data is valid?  The evaluator may also face negative push 
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back from the providers, especially if a quality measure shows they are performing poorly 
compared to their peers. 
Table 6.  Identifying Stakeholders needed for the evaluation 
 
Increase credibility of 
evaluation 
Responsible for 
Implementing the 
activities of the 
program 
Advocate or authorize 
changes the 
evaluation may 
recommend 
Fund or authorize 
continuation or 
expansion of the 
program 
Quality assurance 
organizations 
PHS patients with 
diabetes 
NC IOM 
NC Diabetes 
Prevention and 
Control Program (a 
branch of NC 
Division of Public 
Health) 
PHS Staff: screener, 
physicians, medical 
records, appointment 
secretary, referral 
administrator, 
information 
technology, program 
development director, 
Quality Director 
Image grader 
CEO of PHS 
CMO of PHS 
PHS Providers 
Quality Director 
Program 
Development 
Director, PHS 
 
CEO of PHS 
CMO of PHS 
Funding agency 
Abbreviations: PHS: Piedmont Health Services,  NC IOM: North Carolina Institute of Medicine, 
CEO: Chief Executive Officer, CMO: Chief Medical Officer. 
 
Evaluation Design and Methods 
The primary aim of this program evaluation is to determine the extent to which the program 
objectives were achieved and to describe the impact of the screening program at Piedmont 
Health Services.  The evaluation design is a multiple group time series: The groups are the six 
separate PHS clinic locations, which are evaluated before implementation, as well as several 
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points in time after implementation.  In essence, this time series consists of six individual 
evaluations which, when considered together, form an aggregate evaluation.  
Whereas an experimental design randomly assigns study participants, this study design does 
not manipulate who receives the program; instead, all patients with diabetes are offered 
screening for diabetic retinopathy using the digital retinal camera.  Therefore this quasi-
experimental design examines the degree to which the objectives are achieved at the population 
level.  Although the observational data is likely to exhibit significant improvements in screening 
rates, this evaluation plan is not designed to demonstrate causality.  Instead, the success of the 
program will be indicated by the timing of the change in screening rates.  Absent identification 
of external factors to explain the magnitude of change, the program may be considered 
successful. 
The design uses a mix of quantitative and qualitative methods.  Qualitative data will be 
collected via semi-structured interviews and focus groups to characterize the degree to which 
process objectives are achieved, and to help identify challenges encountered early in the course 
of program implementation.  Semi-structured interviews are conducted one-on-one by the 
evaluator, and ask key stakeholders open ended questions to determine if critical processes in the 
implementation were achieved.  The evaluator shall allow the interviewee to guide the dialogue 
to describe unforeseen barriers in the implementation process and lessons learned. 
The quantitative data is acquired through Piedmont Health Service’s electronic medical 
record.  Screening rates are reported for each clinic site and each provider.  The denominator is 
the total number of active patients with diabetes for a given provider (those who have been seen 
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in the previous twelve months); the numerator is the number of those patients who have 
documentation of screening performed in the past twelve months, or for two years for those 
whose previous screening showed no evidence of diabetic retinopathy. 
Focus groups conducted after analysis of the quantitative data will reveal possible 
explanations for differential in screening rates.  The focus group is an open-ended group 
interview of the providers, guided by the PHS CMO to help identify the key ingredients for 
success. 
The primary goal of the program is to prevent vision loss among patients with diabetes at 
PHS; therefore, when a patient suffers vision loss, a case study is appropriate.  The evaluator 
shall perform a rigorous investigation of the existing records and interview the patient’s provider 
and referral specialist for every patient that suffers vision loss. 
The combination of qualitative and quantitative data strengthen the evaluation design by 
balancing a description of what has occurred with a numerical analysis of the population-level 
study outcome.  This evaluation is designed to document the degree that program objectives are 
met; however, this design does not attempt to attribute the changes in screening rates to the 
program or to demonstrate causality.  Triangulation with multiple methods make the evaluation 
more robust and provide an explanation of how and why the program objectives were achieved 
to a certain degree. 
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Evaluation Planning Tables 
Short term Objective 1: By January 1, 2011, a nonmydriatic digital retinal camera will be 
acquired and installed in one clinic location 
Evaluation Questions Stakeholder Evaluation Method 
Was a digital retinal camera 
acquired and installed in a 
clinic by January 1, 2011?  
What facilitated its 
installation? 
PHS staff: CMO, Quality 
Director, Screener 
Semi-structured interview 
Were the needed partnerships 
created? 
Camera vendor, PHS staff: 
CMO, Quality Director, 
Screener, Information 
Technology, Medical Records 
Semi-structured interview 
What were the challenges in 
setting up the camera at the 
first clinic location? 
PHS staff: CMO, Quality 
Director, Screener 
Semi-structured interview 
How were the challenges 
overcome? 
PHS staff: CMO, Quality 
Director, Screener 
Semi-structured interview 
Was there adequate space at 
the location? 
PHS staff: CMO, Quality 
Director, Screener 
Semi-structured interview 
 
Short term Objective 2:  By January 1, 2011, at least two staff members will be trained in the 
protocol for acquisition of digital retinal images  
Evaluation Questions Stakeholder Evaluation Method 
Were two staff members 
trained in acquisition of digital 
retinal images by January 1, 
2001? 
PHS staff: CMO, Quality 
Director, Screener, Trainer 
(camera vendor) 
Semi-structured interview 
What were the challenges in 
training staff members? 
PHS staff: CMO, Quality 
Director, Screener, Trainer 
(camera vendor) 
Semi-structured interview 
How were the challenges 
overcome? 
PHS staff: CMO, Quality 
Director, Screener, Trainer 
(camera vendor) 
Semi-structured interview 
What aspects of the training 
worked best?  Are you 
satisfied with your level of 
knowledge/training skills?   
PHS staff: CMO, Quality 
Director, Screener, Trainer 
(camera vendor)  
Semi-structured interview 
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Short term Objective 3:  By January 31, 2011, at least two staff members will be proficient at 
acquiring images, with a 90% success rate  
Evaluation Questions Stakeholder Evaluation Method 
What was the image 
acquisition success rate of 
each staff member for the 
month of January 2011? 
PHS staff: CMO, Quality 
Director 
Database review: EMR Query. 
What were the reasons for 
failure (ungradable images)? 
Screener Database review: EMR Query 
What were the characteristics 
(age, cataracts, pupil size) of 
the patients whose images 
were ungradeable?  
Screener Database review: EMR Query 
Could the success rate be 
improved with pupil dilation? 
Screener, PHS CMO Database review: EMR Query  
How could the screening 
process be improved? 
Screener Semi-structured interview 
 
Long term Objective 1:  five years after initiating the program, 75% of adult diabetes patients at 
Piedmont Health Services will be screened for diabetic retinopathy in the previous 12 months. 
Evaluation Questions Stakeholder Evaluation Method 
Five years after initiating the 
screening program, what is the 
diabetic retinopathy screening 
rate for patients with diabetes? 
PHS Quality Director Database review: EMR Query 
Which clinic sites have the 
highest screening rates?  
PHS Quality Director Database review: EMR Query 
Which clinic sites have the 
lowest screening rates? 
PHS Quality Director Database review: EMR Query 
What are the relevant 
differences between the sites 
with the highest and lowest 
screening rates? (Why do 
certain clinics have higher or 
lower screening rates than 
others?) 
PHS CMO, Quality Director, 
Providers from each site.  
Focus Group 
Which provider’s patient 
population has the highest 
screening rates? 
PHS Quality Director Database review: EMR Query 
Which provider’s patient PHS Quality Director Database review: EMR Query 
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population has the lowest 
screening rates? 
What are the relevant 
differences between providers 
with the highest and lowest 
screening rates? (Why do 
certain providers have higher 
or lower screening rates than 
others?) 
PHS CMO, Quality Director, 
Providers from each site. 
Focus Group 
Long term Objective 2:  Five years after initiating the program, 90% of patients found to have 
vision threatening retinopathy will be referred and appropriately treated by a specialist. 
Evaluation Questions Stakeholder Evaluation Method 
How many patients had vision 
threatening retinopathy? 
PHS Medical Records, 
Referral specialist 
Database review: EMR Query 
Of the patients with vision 
threatening retinopathy, how 
many were referred to a 
specialist?  How many  
referrals were completed? 
PHS Medical Records, 
Referral specialist 
Database review: EMR Query 
Of the patients with vision 
threatening retinopathy, how 
many were treated with laser 
photocoagulation? 
PHS Medical Records, 
Referral specialist 
Database review: EMR Query 
Long term Objective 3:  10 years after initiating the program, 50% fewer patients will have 
vision loss due to diabetic retinopathy compared to the previous 10 years. 
Evaluation Questions Stakeholder Evaluation Method 
Ten years after initiating the 
program, how many patients 
have vision loss due to 
diabetic retinopathy compared 
to the previous 10 years? 
PHS Quality Director, 
Medical Records 
Pre-implementation chart 
review, Database review: 
EMR Query 
What are the characteristics of 
the patients with vision loss 
due to diabetic retinopathy? 
PHS Quality Director, 
Medical Records 
Database review: EMR Query, 
chart review, case studies. 
Did the patients with vision 
loss due to diabetic 
retinopathy undergo 
screening?  Referral?  
Treatment?  What could be 
done to prevent vision loss 
PHS Quality Director, 
Medical Records, Referral 
specialist 
Database review: EMR Query, 
case studies. 
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among these patients?  What 
lessons can be learned from 
these patients? 
 
Dissemination of Results 
Evaluation findings and recommendations will be disseminated to PHS in the form of a 
written report, with the purpose of providing recommendations for continuous quality  
improvement of the program.  Delivery of evaluation results to potential funding agency are 
dependent on grant criteria.   
In order to keep program evaluation results readable and useful, they shall be brief, and 
present only the key findings and recommendations.  The key audience will be PHS physicians 
and administrators, who will be familiar with the background and program implementation.  The 
key finding of diabetic retinopathy screening rates will be shown in a run charts.  Results from 
interviews and focus groups shall be produced in the form of recommendations supported by 
brief summary rationales.  
A draft of the evaluation findings shall be distributed to the PHS Quality director and 
CMO in order to ensure appropriate interpretation of the results.  Specifically, data queries from 
the EMR are at risk of misinterpretation, depending on the reliability of data entry. 
The evaluation findings will be relevant to a national audience as well.  A poster 
presentation at the annual American Academy of Family Physicians would target clinicians and 
providers who could adapt a similar program intervention into their practice.  Likewise,  the 
   
 
King 60 
 
American Diabetes Association annual conference would be an appropriate venue for 
disseminating the results of the evaluation. 
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Discussion 
 This program plan seeks to prevent vision loss due to complications from diabetes by 
reducing health disparities and improving access to preventive care through the use of digital 
retinal screening at the site of primary care with remote interpretation.  Several studies discussed 
in the literature review have shown this method to be accurate and effective at improving DR 
screening rates.  To successfully reduce the population attributable risk of vision loss among 
patients with diabetes, public health interventions should focus on improving screening and 
access to treatment in high risk subgroups, especially those with low income and minority 
groups.  
Several challenges for implementing a successful screening program that targets high risk 
subgroups remain.  Chief among these is the high cost of a modern integrated digital retinal 
camera that has limited potential to generate revenue at community health center.  The recent 
economic downturn has had a negative impact on availability of funding for capital improvement 
grants.  Likewise, the cost of preventive treatment for uninsured patients and financial 
sustainability from the ophthalmologist’s perspective must be addressed. 
Low cost digital retinal cameras currently in development are on the horizon.  New 
devices that will be on the market soon include a portable digital retinal camera (Vision 
Instruments ViNM1) which will cost less than $5,000.69   Besides costing a fraction of currently 
available systems, it would also make sharing resources between multiple sites more feasible.  
Other promising technologies are low cost handheld devices such as a camera by Optimum 
Technologies.  A small business innovation research grant from the National Eye Institute is 
funding development of this device designed for a primary care physician.  Digital imaging has 
   
 
King 62 
 
improved exponentially in the past decade, and obeys Moore’s law: the number of transistors 
that can be inexpensively placed on a circuit doubles every 20 months.  This will allow future 
generations of retinal cameras to be more affordable. 
Advances in technology alone will not substantially reduce the burden of suffering 
among our most vulnerable populations; rather, key champions are needed to advocate for and 
implement programs tailored to meet the needs of their community.  Epidemiologic surveillance  
and health services research should seek to continually improve quality of care though 
innovative interventions such as this DR screening program.  I believe the skills acquired in the 
Health Care and Prevention Master’s in Public Health program equip me to be a leader and an 
advocate for community based DR screening.  In the future, I aspire to be a champion for 
improving the coordination of preventive care and collaboration between primary care 
physicians and ophthalmologists in the management of chronic disease with ocular 
manifestations. 
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Appendix A.  Organizational Structure of Piedmont Health Services 
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Piedmont Health 
Services 
Physicians, Carrboro 
Community Health 
Center 
Physicians, Charles 
Drew Community 
Center 
Physicians, Scott 
Community Health 
Center 
 
Physicians, Moncure 
Community Health 
Center 
Physicians, Prospect 
Hill Community Health 
Center 
 
Ophthalmologist (Expert Reader) 
Physicians, Siler City 
Community Health 
Center 
 
Retinal Screener Quality Director 
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Appendix B: Common ICD-9 Diagnosis Codes For Fundus Photography 
  
Table I Common ICD-9 Diagnosis Codes 
For Fundus Photography 
2S0.5x Diabetes .-th ophthalmic 
menlestations 
360.50 Fcrelgn body, magnetic, intraocular 
360.60 Fcrelgn body, Intraocular 
361.10 Retinoschlsls 
361.3x Retinal defects wlo detachment 
362.0 1 Background diabetic retinopathy 
362.02 Proll erative diabetic retinopathy 
362.10 Bac~ground retinopathy 
362.11 Hypertensive retinopathy 
362.12 Exudstlve retinopathy 
362.17 Retinal microvascular abnormalities 
362.18 Retinal vasculitis 
362.30 Retinal vascular occlusion 
362.33 Partial arterial occlusion 
362.50 Macular degeneration 
362.51 Nonexudetlve maOJiar degeneration 
362.52 Exudative macular degeneration 
362.53 Cystoid macular degeneration 
362.63 Lattice degeneration 
362.75 Otlhar retinal dystrophies 
362.76 RPE dystrophies 
362.82 Retinal exudates and deposits 
362.84 Retinal ischemia 
365.xx Glaucoma 
3n.ox Papilledema 
377.1x Opbc atrophy 
377.3x Optic neuntis 
3n.4x Oiscrders of optic nerve 
379.34 Posterior d islocation of lens 
743.52 F...,dus cdoboma 
743.55 Congerital mac:Uar changes 
871.x Open wound o f eyeball 
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Appendix C:  North Carolina Vision Resources 
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organization 
contact 
number 
income 
level  
items 
covered  
people 
covered  
ages 
covered  
Medicaid 800-662-7030 
150-185% of 
Federal 
Poverty Level 
Eye exams, eyeglasses 
and other medically 
necessary 
services with prior 
approval. 
U.S. Citizens 
and qualified 
immigrants 
Birth to age 
20 
Health Choice  800-367-2229 
150-200% of 
Federal 
Poverty Level 
Eye exams, eyeglasses 
and other medically 
necessary 
services with prior 
approval. 
U.S. Citizens 
and qualified 
immigrants 
Ages 6-19 
Division of Services for the 
Blind  
919-733-9822 
Below Federal 
Poverty Level 
Eye exams and eyeglasses U.S. Citizens All ages 
Prevent Blindness North 
Carolina/VSP  
800-543-7839 
200% of 
Federal 
Poverty Level 
Eye exams and eyeglasses 
U.S. Citizens or 
child of 
documented 
immigrant with 
Social Security 
number or 
taxpayer ID 
Children 
up to age 
18 
NCAE Foundation 800-662-7924 All 
Eye exams, eyeglasses 
and other medically 
necessary services. 
Any child, U.S. 
Citizen 
or not, enrolled 
in public 
schools. 
School-
aged 
children. 
Must still 
be in public 
school 
Lion’s Foundation 800-662-7401 
Case by case 
basis 
Eye exams, eyeglasses 
and other medically 
necessary services. 
Any child, U.S. 
Citizen 
or not. 
All ages 
Vision USA 
American 
OptometricAssociation 
  
Contact 
Vision USA 
Eye exams and eyeglasses U.S. Citizens All ages 
LensCrafter’s 
Hometown Day 
All 
LensCrafters 
All Eye exams and eyeglasses Anyone All ages 
Governor Morehead School 
(NC School for the Blind) 
919-733-6382 All 
Preschool program, public 
school consultation, 
residential school in 
Raleigh 
NC residents 
Birth to age 
21 
To find out more about programs and services at Prevent Blindness North Carolina, call 919-755-5044. 
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Appendix D: EYEPACs Educational Flyer (Spanish)67  
SI USTED ES DIABETICO 
 
Sus ojos deben ser examinados una vez al año  
para determinar la presencia de 
RETINOPATIA. 
Este servicio está disponible en esta clínica.  
Es un examen rápido, fácil, y no causa dolor.   
Pregunte por más información hoy! 
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Appendix E: EYEPACs Educational Flyer (English)67   
DIDYOU KNOW 
that between 40-50% of diabetics have 
RETINOPATHY? 
Diabetic retinopathy is an eye condition that 
often has no symptoms but can 
lead to blindness. 
A simple, painless photograph of your eye 
is all it takes to diagnose 
retinopathy and take action. 
Call to find out about the inexpensive test that 
could save your sight. 
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